PharmaSGP Holding SE Working Capital to Net Assets Ratio
PharmaSGP Holding SE working capital to net assets ratio. PharmaSGP Holding SE (PSG) has a Working Capital to Net Assets ratio of 102.1% as of March 2025. Working capital of €37.44 Million (current assets of €59.73 Million minus current liabilities of €22.28 Million) is measured against net assets of €36.67 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of PharmaSGP Holding SE to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of PharmaSGP Holding SE (2014–2024)
Working capital to net assets ratio of PharmaSGP Holding SE from 2014 to 2024. This chart shows how PharmaSGP Holding SE's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2014 to 2024. As of March 2025, the ratio stands at 102.1%, reflecting working capital of €37.44 Million against net assets of €36.67 Million EUR. See PharmaSGP Holding SE (PSG) defensive interval to measure how many days the company can operate on defensive assets alone.
PharmaSGP Holding SE Working Capital to Net Assets Ratio by Year (2014–2024)
PharmaSGP Holding SE working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for PharmaSGP Holding SE from 2014 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PSG total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 95.9% | €30.64 Million | €31.96 Million | €53.67 Million | €23.03 Million | ▼ -0.3 pp |
| 2023 | 96.1% | €38.22 Million | €39.75 Million | €62.82 Million | €24.59 Million | ▲ +3.6 pp |
| 2022 | 92.5% | €28.77 Million | €31.10 Million | €51.51 Million | €22.74 Million | ▲ +363.7 pp |
| 2021 | -271.2% | €-60.20 Million | €22.20 Million | €32.53 Million | €92.73 Million | ▼ -352.3 pp |
| 2020 | 81.1% | €9.33 Million | €11.51 Million | €22.36 Million | €13.04 Million | ▼ -17.4 pp |
| 2019 | 98.5% | €94.15 Million | €95.58 Million | €102.09 Million | €7.94 Million | ▼ -19.3 pp |
| 2017 | 117.8% | €72.22 Million | €61.32 Million | €82.58 Million | €10.36 Million | ▲ +75.2 pp |
| 2016 | 42.6% | €24.50 Million | €57.53 Million | €39.09 Million | €14.60 Million | ▼ -15.3 pp |
| 2015 | 57.9% | €31.13 Million | €53.79 Million | €46.33 Million | €15.20 Million | ▲ +24.3 pp |
| 2014 | 33.6% | €16.20 Million | €48.27 Million | €35.99 Million | €19.79 Million | — |